Market positioning H&T Presspart is a long-standing developer and manufacturer of drug delivery devices with global manufacturing and sales reach, presenting opportunities to upsell existing customers across regions and deepen partnerships in parenteral and biologics markets.

Strategic acquisitions The Plas-Tech acquisition expands capabilities in small-batch parenteral production and Equinox prefillable syringes, enabling cross-sell of modular tooling, prototyping, and end‑to‑end manufacturing services to pharma device programs seeking scalable and specialized packaging solutions.

Inhalation & devices Active sponsorships and participation in inhalation and aerosol events (ISAM, Inhalation Drug Delivery summit) signal focus areas and provide openings to target customers developing inhaled therapies with component and device needs.

Global footprint Sites across multiple Europe and North America with sales representation in China, India, and Uruguay create opportunities to pursue regional deployments, co-development programs, and localized regulatory support for multinational pharma clients.

Partnerships & modernization Recent collaborations and digital/ERP transformation partnerships position H&T Presspart as a modernization partner for customers seeking improved time‑to‑market, process optimization, and integrated supply chain capabilities for drug-device programs.